In CKD, hepatic LRP-1 and LDLR and peripheral tissue VLDLR are down-regulated; LRP-1 and LDLR also decline in MAFLD, whereas VLDLR is markedly up-regulated in advanced steatosis [88]. This evidence concerns the gene VLDLR and chronic kidney disease.